Published on 6 Nov 2023 on GuruFocus.com via Yahoo Finance

Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results

Fulgent Genetics Inc (NASDAQ:FLGT) reports Q3 2023 total revenue of $85 million, with core revenue growing 17% YoY to $66 million.The company records a GAAP loss of $13.1 million, or $0.44 per share, and a non-GAAP loss of $11.7 million, or $0.39 per share.FLGT generated cash flow from operations of $10.2 million and held cash, cash equivalents, and investments in marketable securities of $851 million as of September 30, 2023.FLGT reiterates its full-year 2023 core revenue guidance of $260 million.

Warning! GuruFocus has detected 3 Warning Sign with FLGT.

On November 3, 2023, Fulgent Genetics Inc (NASDAQ:FLGT) announced its financial results for the third quarter ended September 30, 2023. The company reported a total revenue of $85 million, with core revenue growing 17% year-over-year to $66 million. The core revenue excludes revenue from COVID-19 testing products and services.